| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 18 | — | 17.8x | Bottom tier | |
Growth | 84 | — | 7.1% | Top tier | |
Quality | 8 | -58.5% | 4.5% | Bottom tier | |
Safety | 96 | — | 2.6x | Top tier | |
Capital Return | 54 | — | 2.12% | Around median | |
Momentum | 46 | 771.8% | 2.9% | Around median | |
Sentiment | 89 | 3 | 3 | Top tier |
Relmada Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Relmada Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
Estimates — analyst targets and a simplified DCF, not investment advice.
AI analysis from the earnings call, financials and news
